Guanidine

Guanidine

SCHEMBL8400928

Cn1c(=O)c2c(ncn2CC=O)n(C)c1=O.N=C(N)N

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2

The experimentally established mechanism targets of Guanidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 11/20 0.65
LMNA P02545 3/20 0.60
MAPT P10636 1/20 0.57
SMN1; SMN2 Q16637 4/20 0.56
POLB P06746 1/20 0.54
RXFP1 Q9HBX9 2/20 0.53
MAPK1 P28482 1/20 0.53
KMT2A Q03164 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4529535 0.92 ADORA2B (0.76) ADORA2BLMNAMAPTSMN1; SMN2POLB
SCHEMBL14520056 0.84 ADORA2B (0.61) ADORA2BLMNAMAPTSMN1; SMN2POLB
SCHEMBL14520057 0.81 ADORA2B (0.57) ADORA2BLMNAMAPTSMN1; SMN2POLB
SCHEMBL11018328 0.80 ADORA2B (0.70) ADORA2BLMNAMAPTSMN1; SMN2POLB
SCHEMBL17633964 0.80 ADORA2B (0.70) ADORA2BLMNAMAPTSMN1; SMN2POLB
SCHEMBL10354149 0.79 ADORA2B (0.68) ADORA2BLMNAMAPTSMN1; SMN2RXFP1
SCHEMBL316279 0.79 ADORA2B (1.00) ADORA2BLMNAMAPTSMN1; SMN2RXFP1
SCHEMBL19370573 0.78 ADORA2B (0.71) ADORA2BLMNAMAPTSMN1; SMN2POLB
SCHEMBL16120984 0.78 ADORA2B (0.81) ADORA2BLMNAMAPTSMN1; SMN2POLB
SCHEMBL660023 0.78 ADORA2B (0.76) ADORA2BLMNAMAPTSMN1; SMN2RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5958933-A HAVING A GUANIDINO GROUP ALIPHATICALLY LINKED TO A XANTHINE GROUP, ADRENERGIC STIMULANTS NAFTCHI N ERIC (US) 1999-09-28 US disclosed